CUSIP: 00370M103
Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.01 per share
-
Shares outstanding
-
78,459,900
-
Total 13F shares
-
30,664,346
-
Share change
-
-1,096,424
-
Total reported value
-
$234,581,803
-
Price per share
-
$7.65
-
Number of holders
-
43
-
Value change
-
-$5,694,979
-
Number of buys
-
22
-
Number of sells
-
19
Quarterly Holders Quick Answers
What is CUSIP 00370M103?
CUSIP 00370M103 identifies ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2025
-
Previous quarter:
Q1 2025
Recent filing periods for CUSIP 00370M103:
Institutional Holders of Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) as of Q2 2025
As of 30 Jun 2025,
Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,664,346 shares.
The largest 10 holders included
TCG Crossover Management, LLC, Deep Track Capital, LP, ADAR1 Capital Management, LLC, Cormorant Asset Management, LP, Caligan Partners LP, Nantahala Capital Management, LLC, FRANKLIN RESOURCES INC, VR ADVISER, LLC, GREAT POINT PARTNERS LLC, and Octagon Capital Advisors LP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.